Skip to main content
. Author manuscript; available in PMC: 2010 Feb 11.
Published in final edited form as: Clin Cancer Res. 2008 Nov 15;14(22):7511. doi: 10.1158/1078-0432.CCR-08-0839

Fig. 4.

Fig. 4

Effect of bortezomib on P-Akt in vivo. P-Akt was quantified using immunohistochemistry as described in Materials and Methods. P-Akt is increased in the radical prostatectomy tissues of bortezomib-treated patients compared with controls (A) and the preoperative biopsies (B).